Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome

Journal of Gene Medicine

Volumn 11, Issue 3, 2009, Pages 197-206

  Pham, Linh ^a   Nakamura, Takafumi ^a,b   Rosales, A Gabriela ^a   Carlson, Stephanie K ^a   Bailey, Kent R ^a   Peng, Kah Whye ^a   Russell, Stephen J ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

hCG; Adenoviral vector; CEA; Gene expression concordance; Sodium iodide symporter

Indexed keywords

ADENOVIRUS VECTOR; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; RADIOACTIVE IODINE; RECOMBINANT ADENOVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; ADENOVIRUS; ANIMAL; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; MOUSE; NUDE RAT; REPORTER GENE;

ADENOVIRIDAE; CYTOMEGALOVIRUS; MUS; RATTUS;

ADENOVIRIDAE; ANIMALS; CARCINOEMBRYONIC ANTIGEN; CELL LINE; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GENOME, VIRAL; HUMANS; MICE; MICE, NUDE; RATS; RATS, NUDE; TRANSGENES;

EID: 65349169495     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1289     Document Type: Article

References (42)

1. Yoshimasu T, Maebeya S, Suzuma T, et al. Disappearance curves for tumor markers after resection of intrathoracic malignancies. Int J Biol Markers 1999; 14: 99-105.
2. Martin K, Halpern S. Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res 1984; 44: 5475-5481.
3. Go V. Carcinoembryonic antigen: clinical application. Cancer 1976; 37: 562-566.
4. Bidart J-M, Thuillier F, Augereau C, et al. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin Chem 1999; 45: 1695-1707.
5. Shih I-M, Torrance C, Sokoll L, et al. Assessing tumors in living animals through measurement of urinary β-human chorionic gonadotropin. Nat Med 2000; 6: 711-714.
6. Dadachova E, Carrasco N. The Na/I symporter (NIS): imaging and therapeutic applications. Semin Nucl Med 2004; 34: 23-31.
7. Dwyer RM, Bergert ER, O'Connor MK, et al. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther 2006; 17: 661-668.
8. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: current status and future prospects. Thyroid 2004; 14: 424-434.
9. Dingli D, Diaz RM, Bergert ER, et al. Genetically targeted radiotherapy for multiple myeloma. Blood 2003; 102: 489-496.
10. Dingli D, Peng KW, Harvey ME, et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004; 103: 1641-1646.
11. Siddiqui F, Barton KN, Stricker HJ, et al. Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials. Hum Gene Ther 2007; 18: 312-322.
12. Carlson SK, Classic KL, Hadac EM, et al. In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol 2006; 8: 324-332.
13. Mizuguchi H, Xu ZL, Sakurai F, et al. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther 2003; 14: 1265-1277.
14. Peng KW, Facteau S, Wegman T, et al. Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat Med 2002; 8: 527-531.
15. Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994; 47: 157-166.
16. Nyberg-Hoffman C, Shabram P, Li W, et al. Sensitivity and reproducibility in adenoviral infectious titer determination. Nat Med 1997; 3: 808-811.
17. Hasegawa K, Pham L, O'Connor MK, et al. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Clin Cancer Res 2006; 12: 1868-1875.
18. Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nucl Med Biol 2007; 34: 791-807.
19. Harvey B, Hackett N, El-Sawy T, et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol 1999; 73: 6729-6742.
20. Li D, Duan L, Freimuth P, et al. Variability of adenvovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 1999; 5: 4175-4181.
21. Zabner J, Ramsey B, Meeker D, et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 1996; 97: 1504-1511.
22. Fairman J, Roche L, Pieslak I, et al. Quantitative RT-PCR to evaluate in vivo expression of multiple transgenes using a common intron. Biotechniques 1999; 27: 572-574.
23. Gambhir S, Barrio J, Herschman H, et al. Assays for noninvasive imaging of reporter gene expression. Nuclear Med Biol 1999; 26: 481-490.
24. Gussoni E, Wang Y, Fraefel C, et al. A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol 1996; 14: 1012-1016.
25. Tada M, Sakuma S, Iggo R, et al. Monitoring adenviral p53 tansduction efficiency by yeast functional assay. Gene Therapy 1998; 5: 339-344.
26. Gambhir S, Bauer E, Black M, et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000; 14: 2785-2790.
27. Jacobs A, Tjuvajev JG, Dubrovin M, et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res 2001; 61: 2983-2995.
28. Dingli D, Kemp BJ, O'Connor MK, et al. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2006; 8: 16-23.
29. Groot-Wassink T, Aboagye EO, Glaser M, et al. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002; 13: 1723-1735.
30. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123.
31. Rosengart T, Lee L, Patel S, et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100: 468-474.
32. Laitinen M, Hartikainen J, Hiltunen M, et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Human Gene Ther 2000; 11: 263-270.
33. Lozier J, Metzger M, Donahue R, et al. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood 1999; 94: 3968-3975.
34. VandenDriessche T, Vanslembrouck V, Goovaerts I, et al. Longterm expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc Natl Acad Sci USA 1999; 96: 10379-10384.
35. Ye X, Rivera V, Zoltick P, et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 1999; 283: 88-91.
36. Ray S, Paulmurugan R, Patel MR, et al. Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy. Mol Ther 2008; 16: 1848-1856.
37. Bartoli M, Poupiot J, Goyenvalle A, et al. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies. Gene Ther 2006; 13: 20-28.
38. Maelandsmo GM, Ross PJ, Pavliv M, et al. Use of a murine secreted alkaline phosphatase as a non-immunogenic reporter gene in mice. J Gene Med 2005; 7: 307-315.
39. Zoltick P, Wilson J. A quantitative nonimmunogenic transgene product for evaluating vectors in nonhuman primates. Mol Ther 2000; 2: 657-659.
40. Hwang do W, Kang JH, Chang YS, et al. Development of a dual membrane protein reporter system using sodium iodide asymporter and mutant dopamine D2 receptor transgenes. J Nucl Med 2007; 48: 588-595.
41. Dingli D, Bergert ER, Bajzer Z, et al. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun 2004; 325: 157-166.
42. Herschman HR. PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. Crit Rev Oncol Hematol 2004; 51: 191-204.